EGFR and spinal cord injury: Furthermore, both AG1478 (an EGFR antagonist) and C225 (anti-EGFR monoclonal antibody) reportedly reduced the expression of phosphorylated EGFR (p-EGFR), enhanced axonal outgrowth and promoted functional recovery in rats subjected to spinal cord injury (SCI) [14].